56 related articles for article (PubMed ID: 3455740)
1. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2).
Fountzilas G; Gratzner H; Lim LO; Yunis AA
J Natl Cancer Inst; 1986 Jan; 76(1):37-43. PubMed ID: 3455740
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of chemotherapy of renal cell carcinoma. 1. Combination effect through the use of cell kinetics-directed treatment schedules].
Konami T
Hinyokika Kiyo; 1987 Jan; 33(1):1-14. PubMed ID: 3577958
[TBL] [Abstract][Full Text] [Related]
4. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Ohnuma T; Okano T; Holland JF
Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study of chemotherapy of renal cell carcinoma. 2. Combination effect of interferon and antitumor agents based on cell kinetic analysis].
Konami T
Hinyokika Kiyo; 1987 Jan; 33(1):15-26. PubMed ID: 3577963
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of cultured human pancreatic carcinoma cells to dihydroxyanthracenedione.
Fountzilas G; Gratzner H; Lim LO; Yunis AA
Int J Cancer; 1984 Mar; 33(3):347-53. PubMed ID: 6698638
[TBL] [Abstract][Full Text] [Related]
7. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
OKunewick JP; Buffo MJ; Kociban DL
Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
[TBL] [Abstract][Full Text] [Related]
8. Sequence dependence of Alimta (LY231514, MTA) combined with doxorubicin in ZR-75-1 human breast carcinoma cells.
Schultz RM; Dempsey JA
Anticancer Res; 2001; 21(5):3209-14. PubMed ID: 11848474
[TBL] [Abstract][Full Text] [Related]
9. [Cell cycles of cancer cells and chemotherapy--flow cytometric observation of the effects of chemotherapeutic agents on cell kinetics of cultured human lung cancer cells].
Shimizu T
Hokkaido Igaku Zasshi; 1983 Sep; 58(5):467-82. PubMed ID: 6662482
[TBL] [Abstract][Full Text] [Related]
10. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro.
Huang Z; Guo KJ; Guo RX; He SG
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258
[TBL] [Abstract][Full Text] [Related]
12. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
Hill BT; Whelan RD
J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
[TBL] [Abstract][Full Text] [Related]
14. [Apoptosis of human pancreatic carcinoma cell lines induced by combinations of chemotherapeutic drugs].
Liao Q; Zhao Y; Cai L; Wu Y; Zhu Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Apr; 21(2):122-5. PubMed ID: 12569667
[TBL] [Abstract][Full Text] [Related]
15. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
Ito Y; Hoshino A; Ohara K; Kamiya O; Nagata K; Kojima T; Kinoshita T; Sugiura I
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
[TBL] [Abstract][Full Text] [Related]
16. Sequence-dependent synergism between dichloromethotrexate and 5-fluorouracil in a human colon carcinoma cell line.
Sobrero AF; Bertino JR
Cancer Res; 1983 Sep; 43(9):4011-13. PubMed ID: 6871843
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.
Avallone A; Di Gennaro E; Bruzzese F; Laus G; Delrio P; Caraglia M; Pepe S; Comella P; Budillon A
Anticancer Drugs; 2007 Aug; 18(7):781-91. PubMed ID: 17581300
[TBL] [Abstract][Full Text] [Related]
18. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
19. Optimum time sequence for the administration of cyclophosphamide and other drugs in vivo.
Mattern J; Wauss K; Volm M
Anticancer Res; 1985; 5(2):173-8. PubMed ID: 4039550
[TBL] [Abstract][Full Text] [Related]
20. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
